ANALYSIS OF TICAGRELOR AND PRASUGREL CORRELATION WITH CYP2C19 GENETIC VARIANTS AS ALTERNATIVE DRUGS FOR CLOPIDOGREL

被引：0
|
作者：
Seo, B. [1 ]
Lee, S. [1 ]
Lee, I. [1 ]
Kim, S. [1 ]
Chiang, J. [1 ]
机构：
[1] Cipherome, San Jose, CA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-022
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia
    Sorich, Michael J.
    Horowitz, John D.
    Sorich, Wassana
    Wiese, Michael D.
    Pekarsky, Brita
    Karnon, Jonathan D.
    PHARMACOGENOMICS, 2013, 14 (16) : 2013 - 2021
  • [32] Pharmacogenetic Analysis of CYP2C19 for Clopidogrel: Ready for Prime Time
    Miller, Joshua R.
    Baudhuin, Linnea M.
    CLINICAL CHEMISTRY, 2025, 71 (03) : 432 - 433
  • [33] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    XENOBIOTICA, 2007, 37 (04) : 342 - 355
  • [34] Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation
    M Takahashi
    T Saito
    M Ito
    C Tsukada
    Y Katono
    H Hosono
    M Maekawa
    M Shimada
    N Mano
    A Oda
    N Hirasawa
    M Hiratsuka
    The Pharmacogenomics Journal, 2015, 15 : 26 - 32
  • [35] Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation
    Takahashi, M.
    Saito, T.
    Ito, M.
    Tsukada, C.
    Katono, Y.
    Hosono, H.
    Maekawa, M.
    Shimada, M.
    Mano, N.
    Oda, A.
    Hirasawa, N.
    Hiratsuka, M.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (01): : 26 - 32
  • [36] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Stefanadis, Christodoulos
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 481 - 482
  • [37] The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway
    Ford, Neville F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1474 - 1483
  • [38] Analysis of CYP2C19 genetic variants with ischaemic events in UK patients prescribed clopidogrel in primary care: a retrospective cohort study
    Pilling, Luke C.
    Turkmen, Deniz
    Fullalove, Hannah
    Atkins, Janice L.
    Delgado, Joao
    Kuo, Chia-Ling
    Kuchel, George A.
    Ferrucci, Luigi
    Bowden, Jack
    Masoli, Jane A. H.
    Melzer, David
    BMJ OPEN, 2021, 11 (12):
  • [39] CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention
    Kassimis, George
    Davlouros, Periklis
    Xanthopoulou, Ioanna
    Stavrou, Eleana F.
    Athanassiadou, Aglaia
    Alexopoulos, Dimitrios
    THROMBOSIS RESEARCH, 2012, 129 (04) : 441 - 446
  • [40] Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack
    Wang, T.
    Pan, Y.
    Lin, J.
    Anand, R.
    Wang, D.
    Johnston, S. C.
    Meng, X.
    Li, H.
    Zhao, X.
    Liu, L.
    Wang, Y.
    Wang, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (09) : 1175 - 1182
12345